Valence 로고
인기
로그인

관심목록에 추가

BlackRock Health Sciences...

NYSE: BME · 실시간 가격 · USD
44.86
+0.46 (1.04%)
종가 기준: Aug 18, 2026, 3:59 PM

BlackRock Health Sciences Trust (BME) Stock Price, Analysis & Data

1.04%
매수호가n/a
시가총액579.78M
매출 (ttm)7.74M
순이익 (ttm)76.97M
베타0.58
EPS (ttm)5.98
P/E (ttm)7.5
선행 P/En/a
P/B (ttm)1.02
P/S (ttm)74.95
Earnings Daten/a
매도호가n/a
거래량34,978
평균 거래량 (20일)45,465
시가44.64
전일 종가44.40
일중 범위44.50 - 44.96
52주 범위35.95 - 44.99
애널리스트n/a
목표주가n/a
배당$3.15 (7.01%)
배당락일2026년 9월 15일

BME 소개

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical ...

[더 보기]
산업 Asset Management
섹터 Financial Services
IPO 일자 Mar 29, 2005
직원 수 n/a
상장 거래소 NYSE
티커 BME
웹사이트 https://www.blackrock.com/investing/products/240227/blackrock-health-sciences-trust-usd-fund
전체 기업 정보

재무 실적

2025년 BlackRock Health Sciences Trust의 매출은 77.54M로, 전년 24.07M 대비 222.1% 증가했습니다. 순이익은 76.97M로, 228.16% 증가했습니다.

재무제표
news image

2개월 전 · 24/7 Wall St.

How Closed-End Funds at a 12% Discount Can Turn $300,000 Into $30,000 a Year

For many single retirees, $30,000 per year on top of Social Security can help cover expenses such as property taxes, Medicare supplement premiums, groceries, and occasional travel. The amount of capit...

news image

2개월 전 · 24/7 Wall St.

The Closed-End Fund Portfolio That Quietly Pays a 71-Year-Old $61,000 a Year on $850,000 and Trades at a Persistent Discount

A 71-year-old retiree holding $850,000 across a basket of closed-end funds is generating roughly $61,000 a year in distributions. That works out to a blended yield of about 7.2%, with several of the u...

news image

4개월 전 · Simply Wall St.

How The B&M European Value Retail (LSE:BME) Narrative Is Shifting After Analyst Recalibration

The updated analyst work keeps B&M European Value Retail’s central fair value anchor at £2.15, so the headline price target level itself is unchanged. Analysts link this steady £2.15 figure to a mix o...

news image

5개월 전 · Motley Fool

The Only Healthcare Stock I Would Buy and Never Sell Is Medtronic

The only healthcare stock I own is Medtronic, and I'm not planning to sell it anytime soon.